Abstract
Lung cancer is the leading cause of cancer death in men and in some countries already the second leading cause of cancer death in women. The incidence of the disease is still rapidly increasing in women, while a levelling off may be taking place in men. The overall five year survival has not improved significantly in the past 30 years and remains less than 10 per cent.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Bleehen, N.M., Jones, D.H., and Slater, A.J. 1982, High dose human lymphoblastoid interferon in the treatment of small cell carcinoma of bronchus, in: “The III World Conference on Lung Cancer, Abstracts”, May 17-20, 1982, p.161, Tokyo, Japan.
Dritschilo, A., Mossman, K., Gray, M., and Sreevalsan, T. 1982, Potentiation of radiation injury by interferon, Am. J. Clin. Oncol., 5:79.
Gresser, I. 1972, Anti-tumor effects of interferon, Advanc. Cancer Res., 16:97.
Gresser, I., and Bourali-Maury, C. 1972, Inhibition by interferon preparations of a solid tumor and pulmonary metastases in mice, Nature New Biol., 236:78.
Gresser, I., Maury, C., and Tovey, M. 1976, Interferon and murine leukemia. VII. Therapeutic effect of interferon preparations after diagnosis of lymphoma in AKR mice. Int. J. Cancer, 17:647.
Habif, D.V., Lipton, R., and Cantell, K. 1975, Interferon crosses blood-cerebrospinal fluid barrier in monkeys, Proc. Soc. Exp. Biol. Med., 149:287.
Hansen, H.H. 1982, Management of small-cell anaplastic carcinoma, 1980-1982, in: “Lung Cancer 1982”, S. Ishikawa, Y. Hayata, and K. Suemasu, eds., Excerpta Medica, Amsterdam-Oxford-Princeton.
Mattson, K., Niiranen, A., Holsti, L.R., Iivanainen, M., Bergström, L., Standertskjöld-Nordenstam, C.G., Tarkkanen, J., Färkkilä, M., Anderson, I., Holsti, P., Kauppinen, H.-L., and Cantell, K. 1982, High-dose human leukocyte interferon given as a five day continuous intravenous infusion followed by low-dose intramuscular maintenance treatment in previously untreated patients with small cell carcinoma of the lung. Preliminary results, Eur. J. Resp. Dis. Suppl., 125:63.
Schlag, P., Schreml, W., and Herfarth, Ch. 1982, Effect of fibroblast interferon (IF-B) on colony forming tumor growth of miscellaneous carcinomas, in: “Proceedings of 13th International Cancer Congress”, Sept. 8-15, 1982, p.243, Seattle, Washington.
Stoopler, M.B., Krown, S.E., Gralla, R.J., Cunningham-Rundles, S., Stewart, W.E., and Oettgen, H.F. 1980, Phase II trial of human leukocyte interferon in non-small cell lung cancer, in: “II World Conference on Lung Cancer, Abstracts”, June 9-13, 1980, p.221, Copenhagen.
Strander, H. 1977, Interferons: antineoplastic drugs? Blut, 35:277.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Mattson, K., Holsti, L.R. (1983). Lung Cancer. In: Sikora, K. (eds) Interferon and Cancer. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1170-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1170-6_11
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1172-0
Online ISBN: 978-1-4684-1170-6
eBook Packages: Springer Book Archive